Decorative dot pattern background image.
Decorative blue shape background image. Decorative blue shape background image. Decorative blue shape background image. Decorative blue shape background image.

HEAL-LAA

Trial Overview

Official Title

Post-Market Real World Outcomes in WATCHMAN FLX™ Pro Left Atrial Appendage Closure (LAAC) Device

Study Purpose

The primary objective of this study is to collect real-world outcomes data on WATCHMAN FLX™ Pro Left Atrial Appendage Closure (LAAC) Device in patients who are implanted with the WATCHMAN FLX Pro device in a commercial clinical setting.

Diagnosis

Atrial Fibrillation

Eligibility

Inclusion Criteria

  • Atrial fibrillation
  • Indication for WATCHMAN FLX™ Pro Device

Exclusion Criteria

  • Intracardiac thrombus or abnormal anatomy
  • Active infection, bleeding problems
  • Contraindications to anticoagulation therapy, aspirin, P2Y₁₂ inhibitors

Intervention

WATCHMAN FLX™ Pro Left Atrial Appendage Closure (LAAC) Device

For more information, visit the U.S. National Library of Medicine clinical trial database.

Key Participation Requirements
Trial Location(s)
Methodist Hospital Methodist Physicians Clinic
Gender
All
Age
19 years and older
Enrollment Status
Available
Phase
Not Applicable
Methodist Health System Trial Code
NCT05809596
Related Specialties